| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b9036c33bbe3f4ea428655b76200f7c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 |
| filingDate |
2002-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2008-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c77936fce552d2606835f91c46d9f71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72510013585d16b68f76303001a1db87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_443f47d9012631d1b764c7f55df0d8e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5bd531c546439036e4f4a0d763e7c76 |
| publicationDate |
2008-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2303859-T3 |
| titleOfInvention |
HUMANIZED ANTIBODY AGAINST FIBROBLASTIC GROWTH FACTOR 8 AND ANTIBODY FRAGMENT. |
| abstract |
Humanized neutralizing antibody against fibroblast growth factor 8 (FGF-8) or an antibody fragment thereof, in which the variable region (region V) of the heavy chain (H chain) of the antibody comprises the amino acid sequence represented by SEC ID No. 16, and in which the V region of the light chain (L chain) of the antibody comprises the amino acid sequence represented by SEQ ID NO: 19. |
| priorityDate |
2001-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |